TJR-Chem, Via Alberto 34C, 21020 Ranco, VA, Italy.
Drug Discov Today. 2011 Feb;16(3-4):164-71. doi: 10.1016/j.drudis.2010.11.014. Epub 2010 Dec 1.
The impact of carboaromatic, heteroaromatic, carboaliphatic and heteroaliphatic ring counts and fused aromatic ring count on several developability measures (solubility, lipophilicity, protein binding, P450 inhibition and hERG binding) is the topic for this review article. Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaromatics≫heteroaromatics>carboaliphatics>heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases. Increasing aromatic ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused aromatic systems have a beneficial effect relative to their nonfused counterparts. Increasing aromatic ring count has a detrimental effect on human bioavailability parameters, and heteroaromatic ring count (but not other ring counts) has increased over time in marketed oral drugs.
本文综述了碳环芳族、杂环芳族、碳脂环和杂脂环的环数以及稠合芳环数对多种可开发性测量指标(溶解度、脂溶性、蛋白结合、P450 抑制和 hERG 结合)的影响。最近的结果表明,环数的增加对可开发性的不利影响按以下顺序排列:碳芳族≫杂芳族>碳脂环>杂脂环,在许多情况下杂脂环具有有益的作用。增加芳环数会对几种与脂溶性和大小无关的可开发性参数产生影响,并且稠合芳环系统相对于非稠合芳环系统具有有益的效果。增加芳环数对人体生物利用度参数有不利影响,并且在上市的口服药物中,杂芳环数(而不是其他环数)随着时间的推移而增加。